Research and Markets: Global Hereditary Angioedema (HAE) Pipeline Insights Study 2015

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/p9sp4m/hereditary) has announced the addition of the "Hereditary Angioedema (HAE)-Pipeline Insights" report to their offering.

Hereditary Angioedema (HAE) Pipeline Insights provides an in-depth analysis of the pipeline assets across Hereditary Angioedema (HAE). The main objective of this report is to track competitor pipeline molecules, related research activities, technology, collaborations, and in-licensing and out-licensing deals. The Hereditary Angioedema (HAE) Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

Hereditary Angioedema (HAE) Pipeline Insights Report covers the Hereditary Angioedema (HAE) pipeline molecules at various stages of development, like pre-registration phase, clinical phases (Phase III, Phase II & Phase I), and pre-clinical and discovery phases. The Report also provides Hereditary Angioedema (HAE) related therapeutic assessments by molecule type, route of administration, monotherapy and combination products. The Report also highlights the discontinued and inactive projects in the pipeline for Hereditary Angioedema (HAE).

Scope

- The report provides a Hereditary Angioedema (HAE) landscape across the globe

- The report provides drug profiles which include product description, MOA, licensors & collaborators, technology, development partner and chemical information

- Coverage of the Hereditary Angioedema (HAE) pipeline on the basis of target, MOA, route of administration, technology involved and molecule type

- The report reviews key players involved in the therapeutics development for Hereditary Angioedema (HAE) and also provides company profiling

- Pipeline products coverage based on various stages of development from NDA filings to discovery.

- Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type

For more information visit http://www.researchandmarkets.com/research/p9sp4m/hereditary.

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For EST Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For EST Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals